U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. PRIORIX
  1. Vaccines, Blood & Biologics

STN:125748
Proper Name: Measles, Mumps and Rubella Vaccine, Live
Tradename: PRIORIX
Manufacturer: GlaxoSmithKline Biologicals SA
Indications:

  • For active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

Product Information

  • Package Insert - PRIORIX
  • Demographic Subgroup Information – Measles, Mumps and Rubella Vaccine, Live (PRIORIX)
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

 

Back to Top